title: CYP2E1 expression in bone marrow and its intra- and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk assessment of chemicals.
abstract: When characterizing the health risks for man by exposure to chemicals, species-specific differences have to be taken into consideration, otherwise extrapolation from animal data to the human situation would be inadequate. The site-specific toxicity of chemicals may be explained by the following alternatives: (1) reactive metabolites are generated in the liver and subsequently transported to the target tissue(s); (2) metabolism of the parent compound occurs in the target tissue, a pathway by which the enzymes necessary for activation must be expressed in the target tissue. Cytochrome P450 2E1 (CYP2E1) is an important phase-I enzyme activating several chemicals. In the study described in this paper, myeloid intra- and interspecies variability in the expression of CYP2E1 has been investigated in rats, rabbits and man, because the bone marrow represents an important target organ for toxic effects of several chemicals, e.g. benzene. CYP2E1 at the protein level was detected by Western blotting and enzyme activities were determined by CYP2E1-dependent hydroxylation of chlorzoxazone (CLX). In the bone marrow of Wistar rats, the CLX hydroxylase activities were within the same order of magnitude (range: 0.1-0.4 pmol/mg protein per min) as previously described for mice (range 0.2-0.8 pmol/mg protein per min), whereas the CYP2E1 activities in two strains of rabbits were significantly higher (range: 1.7-4.7 pmol/mg protein per min) than in the rodents (P < 0.05). In human CD34+ bone marrow stem cells, CYP2E1 could also be detected on the protein level by Western blotting. The data demonstrate a presence of CYP2E1 in the bone marrow of all species investigated, thus supporting the hypothesis of CYP2E1-dependent local metabolism of several chemicals as a factor possibly contributing to their myelotoxicity and haematotoxicity. The data show that intraspecies/intrastrain variability of CYP2E1 activity in rodents is small. However, CYP2E1 activity between rodents and a non-rodent species was quite different indicating considerable interspecies variability.
authors.affiliation: Federal Institute for Health Protection of Consumers and Veterinary Medicine, Berlin (BgVV), Germany.
authors.forename: U
authors.initials: U
authors.lastname: Bernauer
authors.forename: B
authors.initials: B
authors.lastname: Vieth
authors.forename: R
authors.initials: R
authors.lastname: Ellrich
authors.forename: B
authors.initials: B
authors.lastname: Heinrich-Hirsch
authors.forename: G R
authors.initials: GR
authors.lastname: Jänig
authors.forename: U
authors.initials: U
authors.lastname: Gundert-Remy
mesh_terms: D000328:Adult; D000818:Animals; D015153:Blotting, Western; D001853:Bone Marrow / Q000201:enzymology*; D002753:Chlorzoxazone / Q000378:metabolism; D019392:Cytochrome P-450 CYP2E1 / Q000032:analysis*; D005260:Female; D006801:Humans; D006900:Hydroxylation; D008297:Male; D051379:Mice; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D018570:Risk Assessment; D013045:Species Specificity
chemical_list: D019392:Cytochrome P-450 CYP2E1; D002753:Chlorzoxazone